Advanced

Health economic evaluation: why? When? How?

Kobelt, Gisela LU (2013) In Expert Review of Neurotherapeutics 13(12). p.33-37
Abstract
Advances in research and better understanding of the pathophysiology of diseases have resulted in an increase in the number of available health interventions that compete for finite public resources. Explicit choices must therefore be made about funding.
Please use this url to cite or link to this publication:
author
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Expert Review of Neurotherapeutics
volume
13
issue
12
pages
33 - 37
publisher
Future Drugs Ltd
external identifiers
  • wos:000327545100006
  • pmid:24289840
  • scopus:84890048828
  • pmid:24289840
ISSN
1744-8360
DOI
10.1586/14737175.2013.865872
language
English
LU publication?
yes
id
6068c77d-2d64-41ba-9548-ad00bec23d96 (old id 4225251)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/24289840?dopt=Abstract
date added to LUP
2016-04-01 10:10:15
date last changed
2020-08-12 01:30:29
@article{6068c77d-2d64-41ba-9548-ad00bec23d96,
  abstract     = {Advances in research and better understanding of the pathophysiology of diseases have resulted in an increase in the number of available health interventions that compete for finite public resources. Explicit choices must therefore be made about funding.},
  author       = {Kobelt, Gisela},
  issn         = {1744-8360},
  language     = {eng},
  number       = {12},
  pages        = {33--37},
  publisher    = {Future Drugs Ltd},
  series       = {Expert Review of Neurotherapeutics},
  title        = {Health economic evaluation: why? When? How?},
  url          = {http://dx.doi.org/10.1586/14737175.2013.865872},
  doi          = {10.1586/14737175.2013.865872},
  volume       = {13},
  year         = {2013},
}